New Pharmacoeconomic Data on TYSABRI® Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
CAMBRIDGE, Mass. & DUBLIN, Ireland--(BUSINESS WIRE)--Oct. ... more »
|
|||
|
Multiple Sclerosis Info
Search
This Month
|
Sunday, October 15
by
multiplesclerosis
on Sun 15 Oct 2006 10:00 AM CST
New Pharmacoeconomic Data on TYSABRI® Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple SclerosisCAMBRIDGE, Mass. & DUBLIN, Ireland--(BUSINESS WIRE)--Oct. ... more »
by
multiplesclerosis
on Sun 15 Oct 2006 08:21 AM CST
4 October 2006Health Canada Grants Approval of TYSABRI(TM) (natalizumab) for the Treatment of Multiple Sclerosis Following Priority ReviewFirst New Class of Treatment ... more » |
||